The Cancer Control and Survivorship Program ofthe Robert H. Lurie Comprehensive Cancer Center is a multi-disciplinary program focusing on three thematic areas: (a) Measure, Analyze and Interpret Quality of Life (QOL), (b) Understand and Improve Cancer Survivorship, and (c) Symptom Management and Supportive Care. The Program Leader is Frank J. Penedo, PhD, an accomplished clinical health psychologist whose research focuses on psychosocial and biobehavioral determinants of adjustment to cancer and the efficacy of manualized interventions on QOL and health outcomes with emphasis on ethnic minorities, and the Program Co-Leader is Jamie Von Roenn, MD, a distinguished medical oncologist with expertise in palliative oncology education and research. The objective ofthe Cancer Control and Survivorship Program, which is comprised of 38 faculty members from 13 departments and 2 schools is to facilitate and focus research on secondary cancer control and survivorship within the Cancer Center. Between August 2007 and July 2012, there were 545 cancer-relevant publications from the program members, with 26.6% representing intra-programmatic and 31.4% representing inter-programmatic collaborations. A total of 7,138 participants were enrolled in program studies with 2,802 enrolled on intervention studies and 4,336 enrolled on observational or correlative studies. Total cancer relevant funding for the Program is $14,818,344, with 70% coming from peer reviewed funding. Peer reviewed funding is $10,367,715 (total) and $7,612,441 (direct), with $1,819,740 (23.9%) from NCI and $5,792,702 from other peer reviewed sources. Areas of research include: measurement science, determinants of optimal survivorship including basic mechanisms, psychosocial interventions and educational programs, and symptom palliation. The contribution of program efforts in improving quality of life, state ofthe art assessment of patient reported outcomes and palliation of cancer-related physical and psychosocial symptom burden via psychosocial interventions, coupled with community based activities, support the significance of this work. The Program is highly innovative as it involves multiple projects implementing cutting edge technology. The Program actively seeks to improve cancer control and survivorship by developing and implementing methodologically sound, clinically relevant and highly innovative research initiatives that are clinically effective and translational, aimed to reduce the burden of cancer across multiple communities. Members'interests and capabilities span many disciplines. Their integrated focus upon cancer control and survivorship promotes an environment of intra- and inter-program collaboration and productivity.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA060553-20
Application #
8761045
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
20
Fiscal Year
2014
Total Cost
$400,762
Indirect Cost
$143,968
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Yang, Ruiguo; LemaƮtre, Vincent; Huang, Changjin et al. (2018) Monoclonal Cell Line Generation and CRISPR/Cas9 Manipulation via Single-Cell Electroporation. Small 14:e1702495
Buglak, Nicholas E; Jiang, Wulin; Bahnson, Edward S M (2018) Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats. Redox Biol 19:166-178
Zheng, Jianbin; Chen, Long; Skinner, Owen S et al. (2018) ?-Glucocerebrosidase Modulators Promote Dimerization of ?-Glucocerebrosidase and Reveal an Allosteric Binding Site. J Am Chem Soc 140:5914-5924
Takahashi, Satoe; Sun, Willy; Zhou, Yingjie et al. (2018) Prestin Contributes to Membrane Compartmentalization and Is Required for Normal Innervation of Outer Hair Cells. Front Cell Neurosci 12:211
Joyce, Brian T; Zheng, Yinan; Zhang, Zhou et al. (2018) miRNA-Processing Gene Methylation and Cancer Risk. Cancer Epidemiol Biomarkers Prev 27:550-557
Kenney, Grace E; Dassama, Laura M K; Pandelia, Maria-Eirini et al. (2018) The biosynthesis of methanobactin. Science 359:1411-1416
Symes, Yael R; Barrington, Clare; Austin, Jane et al. (2018) Advice to patients undergoing stem cell transplant: Content analysis of survivor peer support narratives. J Health Psychol 23:818-828
Chu, Lan H; Indramohan, Mohanalaxmi; Ratsimandresy, Rojo A et al. (2018) The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages. Nat Commun 9:996
Lewis, Phillip L; Green, Richard M; Shah, Ramille N (2018) 3D-printed gelatin scaffolds of differing pore geometry modulate hepatocyte function and gene expression. Acta Biomater 69:63-70
Ugolkov, Andrey V; Bondarenko, Gennadiy I; Dubrovskyi, Oleksii et al. (2018) 9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma. Anticancer Drugs 29:717-724

Showing the most recent 10 out of 1972 publications